Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf Mounjaro has stopped suppressing your appetite, you are not imagining it. The reduction in hunger that feels so striking in the first weeks of treatment does fade for many people, usually because your body is adapting to the medicine rather than because it has stopped working. Tirzepatide continues to act on your GIP and GLP-1 receptors throughout treatment; the experience of appetite suppression simply becomes less dramatic as your system adjusts. Understanding what is driving the change, and when it is worth raising with your prescriber, can help you stay steady rather than panic. These are prescription-only medicines, and any significant changes to how your treatment is going should always be discussed with the clinician overseeing your care.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Yes, and it is one of the most common questions our prescribers hear. When tirzepatide is new to your system, the reduction in hunger can feel almost startling. Many people describe eating a small portion and feeling full hours later. That response tends to mellow as your body acclimates to the medicine, and this is not a sign that Mounjaro is failing you.
Tirzepatide works by activating both GIP and GLP-1 receptors, slowing gastric emptying and signalling to the brain that you are full. The NHS medicines page for tirzepatide describes this dual mechanism clearly. The effect is still present even when it no longer feels dramatic. Think of it like noise-cancelling headphones: after a few hours, you stop noticing the quiet — it does not mean the headphones stopped working.
Where appetite suppression disappears more sharply or suddenly, particularly if it coincides with a missed dose or a period of illness, that is worth noting. A single missed injection can allow hunger to return within a day or two, simply because blood levels of the medicine have dropped. If you have kept to your injection schedule and the change still feels pronounced, speak to your prescriber before adjusting anything yourself.
Several practical things can muffle the hunger-reducing signal even when Mounjaro is working normally. Poor sleep is one of the most underappreciated. A few nights of disrupted rest can push ghrelin (a hormone that drives hunger) sharply upward, competing with the appetite-suppressing action of tirzepatide. Stress does something similar, partly through cortisol and partly through the habit of reaching for food when you are overwhelmed.
What you eat matters too, and perhaps more than people expect. Highly palatable foods (the kind engineered to be sweet, salty and crunchy all at once) can override satiety signals even in the presence of GLP-1 activity. If your meals have drifted toward snack foods or ultra-processed options, appetite suppression will feel weaker regardless of your dose. Our guide to eating on Mounjaro covers the practical side of this in more detail.
Timing also plays a role. Some people find their appetite feels more controlled in the first three or four days after their weekly injection, then gradually returns toward the end of the week. This is a known pattern with once-weekly medicines, and if you are wondering whether and how Mounjaro suppresses appetite across the full weekly cycle, our dedicated page walks through the evidence in detail. If that end-of-week hunger is the main issue, it is worth discussing the injection day and whether anything else can be adjusted with your prescriber.
Not every dip in appetite suppression warrants a dose change, and self-adjusting is never the right call. The dose schedule for tirzepatide is set by a prescriber following a clinical assessment, and changing it without that review carries real risks, including a sharper return of side effects at a higher dose than your body has adjusted to.
That said, there are situations where a dose review is genuinely appropriate. If you are several months into treatment, have been stable at a dose for at least four weeks, and appetite suppression has reduced to the point where you are consistently eating beyond comfortable fullness and weight loss has plateaued, that conversation belongs with your prescriber. The NICE appraisal of tirzepatide (NICE TA1026) frames effectiveness partly around continued weight loss over six months, which is one of the markers a prescriber will look at when deciding whether to titrate.
At nume, a prescriber reviews your case before every repeat order. If you are experiencing Mounjaro not suppressing appetite as it once did between your last order and your next, that review is the right moment to raise it. There is no need to wait until your next formal check-in, our aftercare team is available seven days a week if something feels urgent before then.
A gradual fade is normal; a complete and sudden disappearance is worth investigating. If hunger has returned fully and quickly, the first thing to rule out is whether the medicine was stored correctly. Mounjaro pens need to be kept refrigerated between 2 and 8 degrees Celsius, and exposure to heat or freezing can affect how the medicine works. Check the Patient Information Leaflet for the exact storage windows, because these matter more than many people realise.
It is also worth checking whether any other medicines or supplements started recently could be interacting, and if you are finding no appetite suppression on Mounjaro at all, our page on that experience helps clarify when the causes are likely to be temporary and when they need clinical attention. This is not something to reason through alone. The detailed look at how tirzepatide affects appetite on our site covers the mechanisms in full, but a prescriber is the right person to look at your specific situation.
If you are weighing up how appetite suppression compares between Mounjaro and other treatments, our treatment overview gives a balanced picture of what the evidence says. And if you are at the earlier stage of deciding whether to start or continue, some people find it helpful to read about having no appetite on Mounjaro and what that experience typically means before speaking to our prescribers through a free consultation. A named clinician, not software, reads your consultation the same day you submit it.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.